Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Visentin

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
Annals of Hematology|February 5, 2026
Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experienceMattia D'Antiga, Nicolò Danesin, Giovanni Leone, et al.
Current Cancer Drug Targets|May 3, 2017
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell DeathElisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, et al.
Journal of the Peripheral Nervous System : JPNS|March 2, 2023
Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosisChiara Briani, Sergio Ferrari, Tamara Berno, et al.
Hematological Oncology|October 4, 2017
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemiaAndrea Visentin, Chiara Briani, Silvia Imbergamo, et al.
British Journal of Haematology|July 26, 2023
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressivenessFilippo Severin, Nayla Mouawad, Edoardo Ruggeri, et al.
Human Pathology|November 21, 2018
Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphomaMarco Pizzi, Livio Trentin, Andrea Visentin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2023
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic TargetsFrancesca Castellani, Andrea Visentin, Erika Schirinzi, et al.
Annals of Hematology|July 17, 2020
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinibGreta Scapinello, Marcello Riva, Antonio Branca, et al.
Journal of Leukocyte Biology|June 18, 2016
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteinsFederica Frezzato, Benedetta Accordi, Valentina Trimarco, et al.
Hematological Oncology|September 20, 2016
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemiaAndrea Visentin, Carmela Gurrieri, Silvia Imbergamo, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Annals of Hematology|February 5, 2026
Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experienceMattia D'Antiga, Nicolò Danesin, Giovanni Leone, et al.
Current Cancer Drug Targets|May 3, 2017
CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell DeathElisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, et al.
Journal of the Peripheral Nervous System : JPNS|March 2, 2023
Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosisChiara Briani, Sergio Ferrari, Tamara Berno, et al.
Hematological Oncology|October 4, 2017
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemiaAndrea Visentin, Chiara Briani, Silvia Imbergamo, et al.
British Journal of Haematology|July 26, 2023
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressivenessFilippo Severin, Nayla Mouawad, Edoardo Ruggeri, et al.
Human Pathology|November 21, 2018
Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphomaMarco Pizzi, Livio Trentin, Andrea Visentin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2023
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic TargetsFrancesca Castellani, Andrea Visentin, Erika Schirinzi, et al.
Annals of Hematology|July 17, 2020
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinibGreta Scapinello, Marcello Riva, Antonio Branca, et al.
Journal of Leukocyte Biology|June 18, 2016
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteinsFederica Frezzato, Benedetta Accordi, Valentina Trimarco, et al.
Hematological Oncology|September 20, 2016
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemiaAndrea Visentin, Carmela Gurrieri, Silvia Imbergamo, et al.
Pageof 20